Neil Herskowitz, Director at AVENUE THERAPEUTICS, INC. (ATXI), bought 5,000 shares at $5.46 ($27K) on 2019-02-25, disclosed to the SEC on 2019-02-25.
Open-market purchase of $27k ATXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ATXI | BUY | 2021-05-07 | $10K | — | Filing → |
| ATXI | BUY | 2020-03-02 | $21K | — | Filing → |
| ATXI | BUY | 2020-02-25 | $93K | — | Filing → |